NCT07159269 Cardiac point-of Care Ultrasound Training Pathway for Emergency Department Advanced Practice Providers
| NCT ID | NCT07159269 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Cardiovascular Disease Acute |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-11-13 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2025-11-13 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to assess emergency medicine physician and advanced practice provider (APP) knowledge and technical skill in performance of a point-of-care ultrasound simulation and just-in-time training pathway to determine the feasibility, acceptability, and usability of the ultrasound training program. By performing this study, we hope to create a standardized training model which could potentially facilitate point-of-care ultrasound (POCUS) clinical performance and thereby improve patient care.
Eligibility Criteria
Inclusion Criteria: * advanced practice providers (APPs) currently working in our ED, with additional APPs as they are hired (expected to be about 75 APPs total within the next 3 years due to expanding staffing needs and coverage models). Exclusion Criteria: * non-APPs such as physicians, nurses, or other clinical staff
Contact & Investigator
Rebecca G Theophanous, MD, MHSc
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT07159269 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Disease Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07159269 currently recruiting?
Yes, NCT07159269 is actively recruiting participants. Contact the research team at rebecca.theophanous@duke.edu for enrollment information.
Where is the NCT07159269 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT07159269 clinical trial?
NCT07159269 is sponsored by Duke University. The principal investigator is Rebecca G Theophanous, MD, MHSc at Duke University. The trial plans to enroll 75 participants.